Suppr超能文献

The effects of serum and human albumin on calcium hydroxyapatite crystal growth.

作者信息

Garnett J, Dieppe P

机构信息

Department of Medicine, Bristol Royal Infirmary, U.K.

出版信息

Biochem J. 1990 Mar 15;266(3):863-8.

Abstract

The effects of potential serum inhibitors upon the growth of calcium hydroxyapatite (HAP) crystals were studied in vivo using a pH-stat system. Whole serum caused a marked decrease in crystal growth in a dose-dependent manner. At a protein concentration of 13 micrograms/ml, whole serum reduced the initial rate of crystal growth from 84 mumol of KOH/h to 48 mumol of KOH/h. Serum components were separated by ultrafiltration (10,000 Da cut-off). The high-molecular-mass fraction containing serum proteins gave an initial rate of crystal growth of 48 mumol of KOH/h compared with 64 mumol of KOH/h given by the low-molecular-mass components. Thus, two-thirds of the inhibitory activity was associated with proteins and other serum macromolecules, whilst the remainder of the activity was associated with the low-molecular-mass components. Albumin-depleted serum showed an initial rate of crystal growth of 59 mumol of KOH/h, whilst albumin purified by affinity chromatography gave an initial rate of crystal growth of 56 mumol of KOH/h at the same protein concentration. Albumin, therefore, not only accounts for half of the protein concentration in serum, but also contributes half of the inhibitory activity of the high-molecular-mass fraction. Heat denaturation of albumin dramatically enhanced the inhibition of HAP seeded growth with the initial rate of crystal growth falling to 27 mumol of KOH/h after treatment compared with 62 mumol of KOH/h before denaturation. Isoelectric focusing indicated that the tertiary and secondary structure, and hence the distribution of surface charge of albumin, are altered by heat denaturation. Gels showed a mixture of species with isoelectric points ranging from 6.0 to 5.0 compared with the native protein value of 4.7. These data suggest that adsorption of serum proteins to the growing HAP crystals is one mechanism of growth inhibition. It is also clear that the most abundant serum protein, albumin, is an important mediator of this process.

摘要

相似文献

3
Inhibition of hydroxyapatite crystal growth by bone proteoglycans and proteoglycan components.
Biochem Biophys Res Commun. 2002 Apr 5;292(3):727-33. doi: 10.1006/bbrc.2002.6699.
4
Effects of heat treatment of calcium hydroxyapatite particles on the protein adsorption behavior.
J Phys Chem B. 2009 Aug 6;113(31):11016-22. doi: 10.1021/jp904481z.
5
Microcalorimetric study of protein adsorption onto calcium hydroxyapatites.
Langmuir. 2007 Feb 13;23(4):2064-70. doi: 10.1021/la062562n.
6
Adsorption and interactions of dentine phosphoprotein with hydroxyapatite and collagen.
Eur J Oral Sci. 2006 Jun;114(3):223-31. doi: 10.1111/j.1600-0722.2006.00347.x.
7
Synthesis of positively charged calcium hydroxyapatite nano-crystals and their adsorption behavior of proteins.
Colloids Surf B Biointerfaces. 2009 Oct 1;73(1):140-5. doi: 10.1016/j.colsurfb.2009.05.011. Epub 2009 May 19.
8
Protein adsorption characteristics of calcium hydroxyapatites modified with pyrophosphoric acids.
Colloids Surf B Biointerfaces. 2007 Aug 1;58(2):98-104. doi: 10.1016/j.colsurfb.2007.02.014. Epub 2007 Feb 25.
10
Interaction of amelogenin with hydroxyapatite crystals: an adherence effect through amelogenin molecular self-association.
Biopolymers. 1998 Oct 5;46(4):225-38. doi: 10.1002/(SICI)1097-0282(19981005)46:4<225::AID-BIP4>3.0.CO;2-R.

引用本文的文献

1
BMP-4 and fetuin A in systemic sclerosis patients with or without calcinosis.
Front Immunol. 2024 Dec 3;15:1502324. doi: 10.3389/fimmu.2024.1502324. eCollection 2024.
2
New insights into the prevention of ureteral stents encrustation.
Open Med (Wars). 2023 Dec 6;18(1):20230854. doi: 10.1515/med-2023-0854. eCollection 2023.
3
Formation of Hydroxyapatite-Based Hybrid Materials in the Presence of Platelet-Poor Plasma Additive.
Biomimetics (Basel). 2023 Jul 9;8(3):297. doi: 10.3390/biomimetics8030297.
4
Caries Management-The Role of Surface Interactions in De- and Remineralization-Processes.
J Clin Med. 2022 Nov 28;11(23):7044. doi: 10.3390/jcm11237044.
5
A Breakthrough in Understanding the Pathogenesis of Molar Hypomineralisation: The Mineralisation-Poisoning Model.
Front Physiol. 2021 Dec 21;12:802833. doi: 10.3389/fphys.2021.802833. eCollection 2021.
8
Tooth Enamel and its Dynamic Protein Matrix.
Int J Mol Sci. 2020 Jun 23;21(12):4458. doi: 10.3390/ijms21124458.
10
The role of fetuin-A in mineral trafficking and deposition.
Bonekey Rep. 2015 May 6;4:672. doi: 10.1038/bonekey.2015.39. eCollection 2015.

本文引用的文献

1
Calcium-acidic phospholipid-phosphate complexes in diseased and normal human bone.
Metab Bone Dis Relat Res. 1982;4(2):151-6. doi: 10.1016/0221-8747(82)90029-7.
2
Molecular aspects of ligand binding to serum albumin.
Pharmacol Rev. 1981 Mar;33(1):17-53.
3
Measurement of inhibitors of calcium phosphate precipitation in plasma ultrafiltrate.
Am J Physiol. 1984 May;246(5 Pt 2):F648-55. doi: 10.1152/ajprenal.1984.246.5.F648.
5
Phospholipids associated with human parotid gland sialoliths.
Arch Oral Biol. 1983;28(7):655-7. doi: 10.1016/0003-9969(83)90015-8.
7
Adsorption of molecules of biological interest onto hydroxyapatite.
Calcif Tissue Int. 1984 Jan;36(1):48-59. doi: 10.1007/BF02405293.
8
Calcification inhibitors in rat and human serum and plasma.
Biochim Biophys Acta. 1984 Jun 15;799(2):115-21. doi: 10.1016/0304-4165(84)90284-8.
9
Calcific diseases. A concept.
Arch Pathol Lab Med. 1983 Jul;107(7):341-8.
10
Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation.
Calcif Tissue Int. 1982 Mar;34(2):169-77. doi: 10.1007/BF02411229.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验